News
Researchers have developed a powerful new tool that makes it easier to study the mix of cell types in human tissue, which is ...
A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results